RxDoctor Payments Data

Elizabeth Roberts, APRN

Family · Martin, TNNPI 1609856822

Payments from drug & device makers

$3,460in general payments, 2019–2025

Across 227 payments — averaging $15.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$800
  • Novo Nordisk$561
  • Pfizer$386
  • Mayne Pharma Commercial LLC$213
  • Sumitomo Pharma America, Inc.$183
  • Biohaven Pharmaceuticals, Inc.$161
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,41599%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,460 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$30,385
Medicare patients
170
Services billed
1,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$31,065
MounjaroTirzepatide21$21,443
GemtesaVibegron15$12,293
PremarinEstrogens, Conjugated32$9,939
Estradiol87$2,288
SynthroidLevothyroxine Sodium23$1,570
Fluconazole68$750
Buspirone Hcl16$724
Desvenlafaxine Succinate ErDesvenlafaxine Succinate17$668
Clobetasol Propionate16$541
Escitalopram Oxalate29$541
Zolpidem Tartrate ErZolpidem Tartrate13$476
Zolpidem Tartrate30$458
Estradiol (Once Weekly)Estradiol13$417
Omeprazole26$408

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$561$31,06535 claims
Lilly USA, LLCMounjaro$107$21,44321 claims
Sumitomo Pharma America, Inc.Gemtesa$183$12,29315 claims
PfizerPremarin$386$9,93932 claims
AbbVieSynthroid$800$1,57023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Martin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →